|
Carboplatin/etoposide Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 2: 1Phase 1/2: 1
Top Sponsors
- Phanes Therapeutics1
- Beijing Tiantan Hospital1
Indications
- Cancer2
- Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)1
- Neuroendocrine Prostate Cancer (NEPC)1
- Large Cell Neuroendocrine Cancer (LCNEC)1
- Neuroendocrine Carcinomas (NEC)1
Other1 trial
Duarte, California1 trial
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.